Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ominous Signs For Valeant In The Allergan Q2 Earnings Call
Seeking Alpha
Wednesday, July 23, 2014 - 4:30pm
tags:
earnings, Valeant Pharmaceuticals, Allergan
Inovio Declares Spin-Laden Victory With DNA Vaccine
TheStreet.com
Wednesday, July 23, 2014 - 11:05am
tags:
Inovio, vaccines, DNA vaccines, cervical cancer
How Teva Pharmaceutical Is Attacking the Generics to Defend Its Turf
TheStreet.com
Wednesday, July 23, 2014 - 11:03am
tags:
Teva Pharmaceutical, generics, Copaxone
Abuse of U.S. generic-drug rules costs consumers billions, report says
Yahoo/Reuters
Wednesday, July 23, 2014 - 10:47am
tags:
generics, FDA
Too Early To Tell For Atara Biotherapeutics IPO
Seeking Alpha
Wednesday, July 23, 2014 - 10:41am
tags:
Atara, IPOs
Biogen Idec (BIIB) Stock Spikes Following Second Quarter Earnings Beat
TheStreet.com
Wednesday, July 23, 2014 - 10:39am
tags:
earnings, Biogen Idec
Gilead Earnings Preview: Non-Sovaldi Sales Bogey Of $2.94B May Be Unrealistic
Seeking Alpha
Wednesday, July 23, 2014 - 9:17am
tags:
earnings, Sovaldi, Gilead Science
Shire plans to spend about $225 million on collaboration over potential Hunter syndrome drug
Yahoo/AP
Wednesday, July 23, 2014 - 9:14am
tags:
Shire, Hunter Syndrome, ArmaGen
Prempro Plaintiffs’ Lawyers Settle $62 Million Fee Fight
Bloomberg
Wednesday, July 23, 2014 - 9:11am
tags:
Prempro, Pfizer, breast cancer, Arkansas
GlaxoSmithKline plc Falls On Drop In Profits And Turnover
Motley Fool
Wednesday, July 23, 2014 - 9:08am
tags:
GSK, earnings
News flash for biopharma bosses: More than half your employees want to leave
Fierce Pharma
Tuesday, July 22, 2014 - 6:04pm
tags:
pharma employees
Puma Biotechnology shares more than triple on postive trial data
Marketwatch
Tuesday, July 22, 2014 - 6:03pm
tags:
Puma Biotechnology, breast cancer, neratinib
Intuitive Surgical Soars on Large Earnings Surprise
Motley Fool
Tuesday, July 22, 2014 - 6:01pm
tags:
Intuitive Surgical, devices, earnings
Allergan Reiterates Plan to Preempt Valeant Offer
TheStreet.com
Tuesday, July 22, 2014 - 5:13pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Bayer/Regeneron Continue to Progress with Eylea
Yahoo/Zacks.com
Tuesday, July 22, 2014 - 5:12pm
tags:
Bayer, Regeneron, Eylea, diabetic macular edema
3 Quotes From Johnson & Johnson's Conference Call You Need to Read
Motley Fool
Tuesday, July 22, 2014 - 5:11pm
tags:
JNJ, Olysio, earnings, biosimilars
Could This 1 Lawsuit Destroy Biogen Idec Stock?
Motley Fool
Tuesday, July 22, 2014 - 5:08pm
tags:
BiogenIdec, Tecfidera, MS, multiple sclerosis, patents, Actavis, Mylan, Synthon Pharmaceuticals, Novartis, Hexal, Sanofi, Zentiva
Galena Gives Sales Team Another Useless Product to Promote
TheStreet.com
Tuesday, July 22, 2014 - 12:01pm
tags:
Galena Biopharma, MonoSol Rx, Zuplenz, chemotherapy-induced nausea and vomiting
Hemispherx achieves high ranking in sensitivity testing against MERS/SARS
Yahoo/Fly on the Wall
Tuesday, July 22, 2014 - 11:59am
tags:
Hemispherx, MERS virus, SARS
Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?
Motley Fool
Tuesday, July 22, 2014 - 11:49am
tags:
JNJ, hepatitis C, Olysio

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.